Esophageal Squamous Cell Carcinoma Clinical Trials in Beijing
4 recruitingBeijing, China
Showing 1–4 of 4 trials
Recruiting
Phase 2
A Study of KC1036 in Combination With PD-1 Antibody and Platinum-based Chemotherapy as First-line Treatment in Patients With Advanced Esophageal Cancer
Esophageal Squamous Cell Carcinoma (ESCC)
Beijing Konruns Pharmaceutical Co., Ltd.60 enrolled1 locationNCT07481058
Recruiting
Phase 3
A Study of Ifinatamab Deruxtecan in Subjects With Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma (ESCC) (IDeate-Esophageal01)
Esophageal Squamous Cell Carcinoma
Daiichi Sankyo510 enrolled88 locationsNCT06644781
Recruiting
Early Phase 1
Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of IPM514 in Patients with Esophageal Squamous Cell Carcinoma
Esophageal Squamous Cell Carcinoma
Peking University74 enrolled1 locationNCT06690476
Recruiting
Phase 3
A Study of KC1036 Versus Investigator's Choice of Chemotherapy in Patients With Advanced Esophageal Cancer
Esophageal Squamous Cell Carcinoma
Beijing Konruns Pharmaceutical Co., Ltd.490 enrolled1 locationNCT06194734